Stockholm - Delayed Quote SEK
Magnasense AB (MAGNA.ST)
0.0829
-0.0002
(-0.24%)
At close: May 9 at 5:12:02 PM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Marco Witteveen | CEO & Director | 2.42M | -- | 1969 |
| Ms. Vicki Johnson | Interim Chief Financial Officer | -- | -- | -- |
| Dr. Vasiliki Fragkou | Chief Operating Officer | -- | -- | 1979 |
Magnasense AB
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Magnasense AB develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs in Sweden and internationally. The company develops a home testing platform for oral health, therapeutic drug monitoring, and infectious diseases. Its product line includes the Veritope technology with intact natalizumab in multiple sclerosis; and the MagniaReader which is utilized in research and veterinary applications. The company was formerly known as AegirBio AB (publ) and changed its name to Magnasense AB in July 2024. Magnasense AB was incorporated in 2019 and is headquartered in Lund, Sweden.
Corporate Governance
Magnasense AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
IMS.ST Invent Medic Sweden AB
0.1750
-0.57%
8ZF.F Polarean Imaging plc
0.0005
-92.86%
A2P.F Synektik Spólka Akcyjna
53.65
-1.47%
NEOLA.ST Neola Medical AB (publ)
2.4400
+0.83%
3XV.F Xvivo Perfusion AB (publ)
27.66
+0.29%
LT3.F Axogen, Inc.
11.40
+1.79%
PHIA.F Koninklijke Philips N.V.
21.40
+0.94%
PHIAa.XC
ISAB.ST Inhalation Sciences Sweden AB
0.6250
+3.31%
EPIS-B.ST Episurf Medical AB (publ)
0.1110
+0.91%